Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates

被引:34
|
作者
Mandal, Mihirbaran [1 ]
Wu, Yusheng [1 ]
Misiaszek, Jeffrey [1 ]
Li, Guoqing [1 ]
Buevich, Alexei [1 ]
Caldwell, John P. [1 ]
Liu, Xiaoxiang [1 ]
Mazzola, Robert D. [1 ]
Orth, Peter [1 ]
Strickland, Corey [1 ]
Voigt, Johannes [1 ]
Wang, Hongwu [1 ]
Zhu, Zhaoning [1 ]
Chen, Xia [2 ]
Grzelak, Michael [2 ]
Hyde, Lynn A. [2 ]
Kuvelkar, Reshma [2 ]
Leach, Prescott T. [2 ]
Terracina, Giuseppe [2 ]
Zhang, Lili [2 ]
Zhang, Qi [2 ]
Michener, Maria S. [3 ]
Smith, Brad [3 ]
Cox, Kathleen [5 ]
Grotz, Diane [5 ]
Favreau, Leonard [5 ]
Mitra, Kaushik [5 ]
Kazakevich, Irina [4 ]
McKittrick, Brian A.
Greenlee, William [1 ]
Kennedy, Matthew E. [2 ]
Parker, Eric M. [2 ]
Cumming, Jared N. [1 ]
Stamford, Andrew W. [1 ]
机构
[1] Merck Res Labs, Dept Global Chem, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[2] Merck Res Labs, Dept Neurosci, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[3] Merck Res Labs, Dept Safety Assessment & Lab Anim Res, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[4] Merck Res Labs, Dept Discovery Pharmaceut Sci, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[5] Merck Res Labs, Dept Pharmacokinet Pharmacodynam & Drug Metab, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
关键词
X-RAY CRYSTALLOGRAPHY; TREATING ALZHEIMERS-DISEASE; IN-VIVO; SECRETASE INHIBITORS; ROBUST REDUCTION; DRUG DISCOVERY; CELL BIOLOGY; POTENT; HYPOTHESIS; EFFICACY;
D O I
10.1021/acs.jmedchem.5b01995
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold. Employing structure-based design, truncation of the cyanophenyl group of 6 that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in 51 was pursued. Optimization of the pyrimidine substituent that binds in the S2' S2 '' pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogues in this series and imparted high BACE1 affinity. These efforts resulted in the discovery of difluorophenyl analogue 9 (MBi-4), which robustly lowered CSF and cortex A beta(40) in both rats and cynomolgus monkeys following a single oral dose. Compound 9 represents a unique molecular shape among BACE inhibitors reported to potently lower central A beta in nonrodent preclinical species.
引用
收藏
页码:3231 / 3248
页数:18
相关论文
共 50 条
  • [41] Design, synthesis and evaluation of 2-amino-imidazol-4-one derivatives as potent β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) inhibitors
    Fan, Tian-Yuan
    Wu, Wen-Yu
    Yu, Shao-Peng
    Zhong, Yue
    Zhao, Chao
    Chen, Min
    Li, He-Min
    Li, Nian-Guang
    Chen, Zhi
    Chen, Sai
    Sun, Zhi-Hui
    Duan, Jin-Ao
    Shi, Zhi-Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (24)
  • [42] The inhibitory effect of chitosan oligosaccharides on β-site amyloid precursor protein cleaving enzyme 1 (BACE1) in HEK293 APPswe cells
    Dai, Xueling
    Chang, Ping
    Li, Xiaoxiao
    Gao, Zhaolan
    Sun, Yaxuan
    NEUROSCIENCE LETTERS, 2018, 665 : 80 - 85
  • [43] β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase
    Sakurai, T
    Wong, HK
    Oyama, F
    Kaneko, K
    Wada, K
    Miyazaki, H
    Kurosawa, M
    De Strooper, B
    Saftig, P
    Nukina, N
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 244P - 244P
  • [44] β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase
    Wong, HK
    Sakurai, T
    Oyama, F
    Kaneko, K
    Wada, K
    Miyazaki, H
    Kurosawa, M
    De Strooper, B
    Saftig, P
    Nukina, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (24) : 23009 - 23017
  • [45] Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain
    Zhang, Lei
    Chen, Laigao
    Dutra, Jason K.
    Beck, Elizabeth M.
    Nag, Sangram
    Takano, Akihiro
    Amini, Nahid
    Arakawa, Ryosuke
    Brodney, Michael A.
    Buzon, Leanne M.
    Doran, Shawn D.
    Lanyon, Lorraine F.
    McCarthy, Timothy J.
    Bales, Kelly R.
    Nolan, Charles E.
    O'Neill, Brian T.
    Schildknegt, Klaas
    Halldin, Christer
    Villalobos, Anabella
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (08) : 3296 - 3308
  • [46] MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease
    Tan, Xianpei
    Luo, Yi
    Pi, Dingfang
    Xia, Liexin
    Li, Zhilian
    Tu, Qiang
    CURRENT NEUROVASCULAR RESEARCH, 2020, 17 (01) : 86 - 92
  • [47] Demonstration of beta-site amyloid precursor protein-cleaving enzyme (BACE) in early and advanced stage of Alzheimer's disease and normal control brains
    Fushimi, S
    Shirabe, T
    Konishi, Y
    Shen, Y
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S396 - S397
  • [48] Role of Beta-Site Amyloid Precursor Protein-Cleaving Enzyme 2 in the Metabolism of Amyloid Precursor Protein in Human Brain Microvascular Endothelial Cells
    He, Tongrong
    Katusic, Zvonimir S.
    STROKE, 2020, 51
  • [49] Structure-based protein kinase inhibitor design
    Echalier, A
    Endicott, JA
    Johnson, LN
    McDonnell, J
    Noble, MEM
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 : S27 - S28
  • [50] Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation
    Lu, Jinxia
    Cao, Qin
    Wang, Chuchu
    Zheng, Jing
    Luo, Feng
    Xie, Jingfei
    Li, Yichen
    Ma, Xiaojuan
    He, Lin
    Eisenberg, David
    Nowick, James
    Jiang, Lin
    Li, Dan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12